[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368635-105":3,"detail-sidebar-cat-0-en-105":84,"doc-detail-368635-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":77,"head_meta":79,"extra_data":81,"updated_unix":83},105,"en","predicting-time-to-first-cancer-diagnosis-across-multiple-cancer-types","Predicting time-to-first cancer diagnosis across multiple cancer types","","The study addresses the challenge of predicting time-to-first cancer diagnosis, driven by the disease’s complex, multifactorial nature. Predictive models were trained using the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial and evaluated with the UK Biobank to estimate time-to-diagnosis for high-incidence cancers, including lung, liver, and bladder. Using Cox proportional hazards with elastic net, survival decision trees, and random survival forests on 46 sex-agnostic features, the Cox model reached a C-index of 0.813 for lung cancer, with consistently superior cancer-specific performance validated by time-dependent AUC.",{"@graph":14,"@context":76},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/predicting-time-to-first-cancer-diagnosis-across-multiple-cancer-types/368635/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/predicting-time-to-first-cancer-diagnosis-across-multiple-cancer-types/368635.png","ImageObject",300,407,{"name":42,"@type":43},"Chumphorn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":33},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68,72],{"name":59,"@type":60,"acceptedAnswer":61},"Why is predicting time-to-first cancer diagnosis difficult?","Question",{"text":62,"@type":63},"Because cancer onset involves complex, multifactorial interactions of genetic, environmental, and lifestyle factors, making risk trajectories hard to model.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"What data sources were used to build and evaluate the models?",{"text":67,"@type":63},"Models were trained using the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial and evaluated using the UK Biobank.",{"name":69,"@type":60,"acceptedAnswer":70},"Which modeling approaches were compared in the study?",{"text":71,"@type":63},"Cox proportional hazards with elastic net regularization, survival decision trees, and random survival forests were used to estimate time-to-diagnosis.",{"name":73,"@type":60,"acceptedAnswer":74},"How did the best model perform for lung cancer?",{"text":75,"@type":63},"The Cox model achieved a C-index of 0.813 for lung cancer, outperforming non-parametric machine learning approaches in accuracy and interpretability.","https://schema.org",{"og:url":32,"og:type":78,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":80,"canonical":32},"index,follow",{"doc_id":82,"site_id":7},368635,1791315900,{"code":4,"msg":85,"data":86},"success",[87,91,95,99,104,109,114,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":96,"show_sort_weight":97,"slug":98},"Exam",70,"exam",{"id":100,"doc_module":4,"doc_module_name":25,"category_name":101,"show_sort_weight":102,"slug":103},5,"Comic",60,"comic",{"id":105,"doc_module":4,"doc_module_name":25,"category_name":106,"show_sort_weight":107,"slug":108},6,"Technology",50,"technology",{"id":110,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},7,"Healthcare",40,"healthcare",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},8,30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":100,"slug":133},19,"General","general",{"code":4,"msg":85,"data":135},{"doc_id":82,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":115,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":33,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":116,"preview_page_count":33,"preview_urls":149},2336475401981,"https://ap-avatar.wpscdn.com/avatar/22000c94efd8d5204d?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786935347598174694","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nPredicting time-to-first cancer diagnosis across multiple cancer types  \nKien Lau1, Gregory R. Hart2 & Jun Deng1􀀍  \nCancer causes over 10 million deaths annually worldwide, with 40.5% of Americans expected to be diagnosed in their lifetime. Early detection is critical; for liver cancer, survival rates improve from 4 to 37% when caught early. However, predicting time to first cancer diagnosis is challenging due to its complex and multifactorial nature. We developed predictive models using the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial for training and the UK Biobank for evaluation to estimate time-to-first cancer diagnosis for high-incidence cancers, including lung, liver, and bladder cancers. Utilizing Cox proportional hazards models with elastic net regularization, survival decision trees, and random survival forests, we used 46 sex-agnostic demographic, clinical, and behavioral features. The Cox model achieved a C-index of 0.813 for lung cancer, surpassing non-parametric machine learning methods in accuracy and interpretability. Cancer-specific models consistently outperformed non-specific cancer models, as shown by time-dependent AUC analyses. Scaled Cox coefficients revealed novel insights, including BMI’s inverse association with lung cancer risk. Our findings offer interpretable, accurate tools for personalized cancer risk assessment, improving early detection and bridging computational advances with clinical practice.  \nCancer remains one of the leading causes of morbidity and mortality worldwide. According to the World Health Organization (WHO), cancer accounted for over 10 million deaths in 2020, representing approximately one in six deaths globally1. In the United States, about 40.5% of men and women are expected to be diagnosed with cancer at some point in their lifetimes2. Early detection significantly improves patient outcomes, as timely intervention and treatment can increase survival rates. For instance, the five-year survival rate for liver cancer detected at a localized stage is about 37%, compared to just 4% when diagnosed at a distant stage3. Similarly, early detection of bladder cancer can increase the five-year survival rate from 8 to 71%4. Despite the clear benefits of early detection, predicting the onset of cancer remains a complex challenge due to the multifactorial nature of the disease and the intricate interplay of genetic, environmental, and lifestyle factors5.  \nTraditional risk assessment tools are often limited, as they tend to rely on single factors or simplistic models that may not capture the complexity of cancer development6. Machine learning has emerged as a promising solution, offering the ability to model complex biological phenomena and enhance predictive accuracy for cancer diagnosis and prognosis7. Survival analysis techniques, such as the Cox proportional hazards model, are widely used to analyze time-to-event data in medical research, particularly in cases with censored observations8. The semi-parametric nature of the Cox model allows it to handle a variety of covariates without specifying the baseline hazard function, making it versatile for studying the relationship between patient characteristics and cancer development. Incorporating regularization techniques such as elastic net further improves the model by addressing multicollinearity and refining feature selection9. However, despite advancements in predictive modeling, significant challenges remain in translating machine learning tools into clinical practice. While there have been substantial advances in explainable AI10, the technical complexity and specialized expertise required to interpret these methods often render such models inaccessible to most end users11. This challenge is particularly acute in high-stakes settings, where deep learning algorithms—despite their high accuracy—are still widely perceived by clinicians as “b","cbCaiuFtI3BzqbfI","https://ap.wps.com/l/cbCaiuFtI3BzqbfI","pdf",2707353,12,"English","# Introduction\n## Clinical impact of early detection\n## Limitations of traditional risk tools\n## Machine learning and explainability needs\n## Generalizability and dataset bias\n# Methods and modeling approach\n## Training and evaluation cohorts\n## Survival models and feature set","[{\"question\":\"Why is predicting time-to-first cancer diagnosis difficult?\",\"answer\":\"Because cancer onset involves complex, multifactorial interactions of genetic, environmental, and lifestyle factors, making risk trajectories hard to model.\"},{\"question\":\"What data sources were used to build and evaluate the models?\",\"answer\":\"Models were trained using the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial and evaluated using the UK Biobank.\"},{\"question\":\"Which modeling approaches were compared in the study?\",\"answer\":\"Cox proportional hazards with elastic net regularization, survival decision trees, and random survival forests were used to estimate time-to-diagnosis.\"},{\"question\":\"How did the best model perform for lung cancer?\",\"answer\":\"The Cox model achieved a C-index of 0.813 for lung cancer, outperforming non-parametric machine learning approaches in accuracy and interpretability.\"}]","Predicting time-to-first cancer diagnosis across multiple cancer types | PDF",1790177802,[150,154,158,162],{"page_no":22,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/29d2d94cb67c1d63c4403af7da623dd7.webp",983,1291,{"page_no":26,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bc70bef12fb8df1fd10a03a5d36647bf.webp",982,1290,{"page_no":30,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/04812b4e13f60b84eab4e369efa4e2d2.webp",981,1289,{"page_no":33,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/05ae46c69522f4615aae5737a57ac073.webp",980,1287]